Ido inhibitor and gallic acid cross-linked small molecule drug synergistic treatment of melanoma

HIGHLIGHTS

• who: Hongmei Liu from the Xuzhou Medical University, Xuzhou, China, Department of Biomedical Engineering, Southern University of Science and have published the research work: IDO Inhibitor and Gallic Acid Cross-Linked Small Molecule Drug Synergistic Treatment of Melanoma, in the Journal: (JOURNAL)
• what: Based on the combination of immunosuppressants approach in clinical trials, the authors propose the combination therapy strategy of natural polyphenol GA and 1MT.
• how: The animals used in the experiment were cared for and used in accordance with the principles of experimental animal care and guidelines for the care and . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.